# Prognostic value of different immunohistopathological patterns and Ki67 proliferation index for Merkel cell carcinoma

**Authors:** Katharina Theresa Obermeier, Wenko Smolka, Maximilian Kollmuss, Sabina Noreen Wuersching, Ina Dewenter, Philipp Poxleiter, Sven Otto, Yoana Malenova, Florian Fegg, Paris Liokatis

PMC · DOI: 10.1186/s13005-025-00578-7 · Head & Face Medicine · 2025-12-23

## TL;DR

This study explores how the Ki67 proliferation index can predict outcomes in patients with Merkel cell carcinoma, a rare and aggressive skin cancer.

## Contribution

The study identifies a specific Ki67 cut-off value (77.5%) as a prognostic marker for Merkel cell carcinoma.

## Key findings

- A Ki67 index above 77.5% was most effective in stratifying patient outcomes.
- Higher Ki67 values correlated with increased risk of metastases and recurrence.
- Elevated Ki67 index was associated with poorer 5-year survival rates.

## Abstract

Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine skin tumor, which preferentially appears in the head and neck area. Overall 5-year survival is about 66–70% in patients with non-metastasized tumors and reduces to 42% in cases with regional metastases, and down to 18% in case of distant metastases. The Ki67- index is one of the most important biological markers in neuroendocrine tumors and is recently known as a prognostic marker in pancreatic neuroendocrine neoplasms. This study aims to evaluate the prognostic role of Ki67 in Merkel cell carcinoma. A cut-off value for Ki67 index was calculated using Youden’s index. Overall, 16 patients were included in this retrospective study. The best matching cutoff value for our data was calculated at 77.5%. Ki67 turned out to be > 85% in patients with local recurrence of MCC and > 90% with lymph node metastases. A Ki67-index of 77.5% stratified the patients in our cohort most efficiently. A safety margin higher than 1 cm should be aimed.

Merkel cell carcinoma is a rare aggressive neuroendocrine skin tumor. General 5-year survival is between 66-70% in patients without metastases. This study aims to present the prognostic role of Ki67 proliferation index in Merkel cell carcinoma. This study shows that a high Ki67-proliferation index is linked to a higher risk for metastases and recurrence. In this study, it was also shown that the elevated Ki67 index was associated with poorer 5-year survival.

## Linked entities

- **Proteins:** Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Diseases:** Merkel cell carcinoma (MONDO:0019210)

## Full-text entities

- **Diseases:** Merkel cell carcinoma (MESH:D015266)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12849675/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12849675/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12849675/full.md

---
Source: https://tomesphere.com/paper/PMC12849675